Virtual Reality in COPD Exacerbation

NCT05687396 | Recruiting

• 1 other identifier: Doktora
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

In addition to conventional pulmonary rehabilitation, virtual reality will be applied during the hospitalization period of individuals hospitalized for COPD exacerbation. It is aimed to get more efficiency from the interventions in this short time.

Conditions

COPD Exacerbation; Pulmonary Rehabilitation

Keywords

COPD, pulmonary rehabilitation, virtual reality

Outcome Measures

Primary Outcomes (5)

• 1 minute sit and stand test

  performance

  5 minutes

• Chronic Obstructive Pulmonary Disease Assessment Test

  The test assessts COPD symptoms, higher scores mean bad stiation

  3-7 days

• London chest activity of daily living

  The test assessts dyspnea that occurs during daily living activities. The total score can range from 0 to 75 points, with higher values translating to greater limitation in activities of daily living.

  3-7 days

• Hospital anxiety and depression scale

  The test has 2 subparameter as anxiety and depression. Each question in the test contains 4 options expressing frequency on a scale 0 to 3. Higher scores mean bad stiation for each parameter.

  3-7 days

• Modified Medical Research Council

  The test has 5 options thas describe dyspnea. Higher scores mean higher dyspnea.

  3-7 days

Study Arms (2)

Virtual reality

EXPERIMENTAL

Virtual reality while cycling with ergometer in addition to conventional pulmonary rehabilitation. virtual reality designed as cylcling in the forest.

Device: virtual reality

Conventional pulmonary rehabilitation

EXPERIMENTAL

Deep diafragmatic breathing exercise, chest expansion exercies, pursed lip exhalation, coughing and huffing, upper limp exercies with deep breathing exercise, standing up-right position, cycling with ergometer.

Other: conventional pulmonary rehabilitation

Interventions

virtual reality DEVICE

virtual reality designed as cycling in the forest

Virtual reality

conventional pulmonary rehabilitation OTHER

pulmonary rehabilitation

Conventional pulmonary rehabilitation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Individuals who are in COPD exacerbation period, FEV1 \<70%, GOLD 2-3 spirometric stage, Hodkinson mental test score \> 6 and who want to participate in the study voluntarily will be included in the study.

You may not qualify if:

• If there is respiratory disease considered more significant than COPD (bronchiectasis, lung cancer requiring active therapy, or asthma), Heart failure New York Heart Association (NYHA) stage 3-4, Significant hemoptysis, surgical or non-surgical lung volume in the past 6 months Individuals with reduction procedures, Lung transplantation or pneumonectomy surgery in the last 6 months, pulmonary embolism or pulmonary edema, acute myocardial infarction, acute heart failure, vertigo, epilepsy and visual impairment will be excluded from the study.

Sponsors & Collaborators

• Pamukkale University: lead

Study Sites (1)

Pamukkale University

Denizli, Pamukkale, 20000, Turkey (Türkiye)

RECRUITING

Related Publications (1)

• Kizmaz E, Telli Atalay O, Cetin N, Ugurlu E. Virtual reality for COPD exacerbation: A randomized controlled trial. Respir Med. 2024 Aug-Sep;230:107696. doi: 10.1016/j.rmed.2024.107696. Epub 2024 Jun 8.

  PMID: 38857811 DERIVED

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Erhan Kızmaz, Msc

  Pamukkale University

  PRINCIPAL INVESTIGATOR

• Orçin Telli Atalay, professor

  Pamukkale University

  STUDY DIRECTOR

Central Study Contacts

Erhan Kızmaz

CONTACT

+905418966676; erhankizmaz@hotmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 25, 2022
• First Posted: January 18, 2023
• Study Start: June 1, 2022
• Primary Completion: April 10, 2024
• Study Completion: April 22, 2024
• Last Updated: April 2, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)